Recent studies have demonstrated localization of hematopoietic stem cells in unexpected peripheral sites. For example, hematopoietic activity in the absence of extramedullary hematopoiesis has been described in skeletal and cardiac muscle. The accumulation and maintenance of hematopoietic cells in tissues such as muscle is difficult to explain. One hypothesis is that primitive hematopoietic cells normally circulate at low frequencies because they play a role in the innate immune response. Consistent with this hypothesis, several pro-inflammatory cytokines have strong co-stimulatory effects on hematopoietic cell proliferation and mobilization. This application seeks to test the hypothesis that bone marrow-related mechanisms can play an important role in peripheral inflammatory responses. The investigator will develop an experimental model to test the hypothesis that mobilization of hematopoietic cells from bone marrow into the peripheral blood is a mechanism which evolved to provide accumulation of these cells in peripheral tissues, where local production of cytokines directs them to expand and differentiate into myeloid cells during the normal response to inflammatory stimuli. As a first aim, experiments will determine if hematopoietic stem and progenitor cells mobilize from the bone marrow in response to peripheral inflammation.
The second aim of the study is to determine if mobilized or transplanted hematopoietic cells accumulate and differentiate within peripheral sites of inflammation. Peripheral inflammatory sites will be analyzed to determine if cells with hematopoietic activity accumulate and differentiate in situ to produce myeloid cells that contribute to the inflammatory response. We will also test the hypothesis that transplanted hematopoietic cells can accumulate in existing sites of peripheral inflammation and contribute to the generation of inflammatory responses in these sites. The results of this study may suggest approaches to limit pathological inflammation that sometimes impacts bone marrow transplant recipients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HL072026-02
Application #
6663199
Study Section
Special Emphasis Panel (ZHL1-CSR-O (S1))
Program Officer
Mitchell, Phyllis
Project Start
2002-09-30
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
2
Fiscal Year
2003
Total Cost
$224,250
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112